AIM Outlines Milestones
AIM ImmunoTech outlines upcoming milestones, including DURIPANC primary endpoint analysis expected in December 2026
AIM ImmunoTech Outlines Upcoming Milestones, Including DURIPANC Primary Endpoint Analysis Expected In December 2026